CN110130099B - Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides - Google Patents

Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides Download PDF

Info

Publication number
CN110130099B
CN110130099B CN201910340139.3A CN201910340139A CN110130099B CN 110130099 B CN110130099 B CN 110130099B CN 201910340139 A CN201910340139 A CN 201910340139A CN 110130099 B CN110130099 B CN 110130099B
Authority
CN
China
Prior art keywords
mhn
nanofiber
gsh
nanoparticles
glycopeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201910340139.3A
Other languages
Chinese (zh)
Other versions
CN110130099A (en
Inventor
李洁
郇伟伟
王步川
吴敏洁
赵佳俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang A&F University ZAFU
Original Assignee
Zhejiang A&F University ZAFU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang A&F University ZAFU filed Critical Zhejiang A&F University ZAFU
Priority to CN201910340139.3A priority Critical patent/CN110130099B/en
Publication of CN110130099A publication Critical patent/CN110130099A/en
Application granted granted Critical
Publication of CN110130099B publication Critical patent/CN110130099B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/32Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/36Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/49Oxides or hydroxides of elements of Groups 8, 9,10 or 18 of the Periodic Table; Ferrates; Cobaltates; Nickelates; Ruthenates; Osmates; Rhodates; Iridates; Palladates; Platinates
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/83Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with metals; with metal-generating compounds, e.g. metal carbonyls; Reduction of metal compounds on textiles
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/402Amides imides, sulfamic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34Purifying; Cleaning
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4044Concentrating samples by chemical techniques; Digestion; Chemical decomposition
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • G01N33/6851Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Textile Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides a magnetic nanofiber-based zwitter-ion hydrophilic material for selectively capturing and identifying glycopeptides, which is used for enriching and identifying the glycopeptides; one-dimensional Hydroxyapatite Nanofiber (HN) is used as a carrier to fix Fe3O4Nanoparticles and Au nanoparticles, via the thiol group of the zwitterionic tripeptide L-glutathione with Au and Fe3O4The surface modification is carried out through the affinity interaction between the two to form mHN/Au-GSH nano-fiber. mHN/Au-GSH nanofiber has high glycopeptide detection sensitivity (2fmol), high recovery rate (89.65%), strong binding capacity (100mg/g) and high enrichment selectivity (1: 100).

Description

Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides
Technical Field
The invention relates to a magnetic nanofiber-based zwitter-ion hydrophilic material for selectively capturing and identifying glycopeptides, and belongs to the technical field of biochemical analysis.
Background
Proteins/peptides, carbohydrates, nucleic acids, etc. as essential and important biological components mediate most of the fundamental biological processes such as cellular communication, immune reactions and enzymatic reactions. Due to the complex composition and severe interference, the detection and characterization of target biological macromolecules is a great challenge, especially for low abundance analytes. Thus, sample preparation is an indispensable step in the analytical process. The development of affinity materials for selective separation and preconcentration of target biological macromolecules is an effective method to reduce impurity interference and improve detection sensitivity. To date, a variety of materials have been developed, including silica, mesoporous silica, magnetic nanoparticles, Au nanoparticles, polymers, graphene oxide, metal organic frameworks, and porous organic frameworks, for biomacromolecule extraction. The design and synthesis of affinity materials for highly selective capture and identification of target biological macromolecules remains an important research topic.
Glycoproteins are involved in a variety of biological processes and are also biomarkers for several diseases. The comprehensive identification of the glycoprotein not only can understand the physiological process, but also is beneficial to the discovery of biomarkers. The current popular glycopeptide omics analysis method based on mass spectrum comprises proteolysis, glycopeptide enrichment and mass spectrum identification. Based on the structural differences between glycopeptides and non-glycopeptides, several affinity materials including lectins, hydrazine beads, boronic acids, and hydrophilic adsorbents have been introduced to identify and separate glycopeptides and non-glycopeptides abundant in living organisms. In contrast, the hydrophilic interaction separation method has the advantages of high enrichment efficiency, wide glycan specificity, irreversible change of glycan components and the like.
Many hydrophilic materials have been proposed for the enrichment and identification of glycopeptides. Notably, various hydrophilic materials have been combined with magnetic nanoparticles to achieve magnetic response capabilities, making the separation process simple and efficient.
However, the synthesis of these hydrophilic materials often requires complex synthetic procedures, multi-step functionalization, and longer incubation times. This cumbersome process greatly increases the cost of the analytical methods, greatly limiting their application to practical samples. Therefore, more hydrophilic materials with abundant structural features need to be excavated to realize simple and efficient enrichment of glycopeptides.
Disclosure of Invention
The invention aims at the problems, thereby providing a magnetic nanofiber-based zwitter-ion hydrophilic material for selectively capturing and identifying glycopeptides, which has the characteristics of good hydrophilicity, abundant zwitter-ion glutathione molecules and strong magnetic responsiveness, and has better specificity and efficiency in the aspect of glycopeptide enrichment.
The specific technical scheme is as follows:
magnetic nanofiber-based zwitterion hydrophilic material for selectively capturing and identifying glycopeptides, and hydroxyapatite nanofiber is used as a carrier to fix Fe3O4Nanoparticles and Au nanoparticles, via the thiol group of the zwitterionic tripeptide L-glutathione with Au and Fe3O4The surface modification is carried out through the affinity interaction between the two to form mHN/Au-GSH nano-fiber.
Further, the preparation method of the mHN/Au-GSH nano fiber comprises the following steps:
s1: dispersing 2.0g of hydroxyapatite nanofiber and 0.75g of ferric acetylacetonate in 400mL of triethylene glycol to obtain a mixture;
s2: the mixture was transferred to a 1L autoclave and reacted at 220 ℃ for 12 hours, washed with water and ethanol to give fixed Fe3O4A nanofiber product of nanoparticles mHN;
s3: 0.5g of prepared mHN and 25mL of tetrachloroaurate trihydrate were added to 1L of deionized water to obtain a suspension;
s4: the suspension was stirred at 25 ℃ for 12 hours, 50mg of sodium borohydride was added and stirred for 30 minutes to obtain simultaneous fixed Fe3O4Nanofiber product mHN/Au of nanoparticles and Au nanoparticles;
s5: after washing with deionized water, 0.5g of the HN/Au product was dispersed in an aqueous solution containing 2g of glutathione; stirring at 50 deg.C for 10 hr to obtain mHN/Au-GSH nanofiber.
Further, the concentration of tetrachloroauric acid trihydrate in S3 was 2 mg/mL.
Further, mHN/Au-GSH nanofiber is used for enrichment and identification of glycopeptide.
Furthermore, the mHN/Au-GSH nano-fiber can be used for pretreatment before ionization time-of-flight mass spectrometry analysis of human immunoglobulin, chicken avidin protein or bovine serum albumin; the method comprises the following specific steps:
s1: digesting human immunoglobulin, chicken avidin or bovine serum albumin with trypsin;
s2: 400 u g mHN/Au-GSH nanofibers and 2.5 u g human immunoglobulin digests, chicken avidin digests or bovine serum albumin digests into 400 u L buffer solution, at 25 degrees C temperature in 15 minutes;
s3: magnetically separating the material, washing with 2 × 400 μ L buffer solution, and adding 20 μ L eluent to elute and capture glycopeptide;
s4: depositing 1 μ L of the eluate and 1 μ L of DHB on a MALDI plate, and performing MALDI-TOFMS analysis;
in the above pretreatment process, the buffer solution is ACN-H2O-TFA, 92: 7.9: 0.1, v/v/v; the eluent is ACN-H2O, 30: 70, v/v; the concentration of DHB was 25 mg/mL.
Further, the mHN/Au-GSH nanofiber can be used for pretreatment before nano-LC-MS/MS analysis of human serum; the method comprises the following specific steps:
s1: trypsinizing human serum;
s2: 2mg of mHN/Au-GSH nanofibers were incubated with 5. mu.L of human serum digest in 1mL of buffer for 30 min;
s3: adding 2 × 100 μ L of the eluate, and lyophilizing the obtained eluate;
s4: the lyophilized sample was redissolved in 100. mu.L of 25 mmol. multidot.L-1To the sodium bicarbonate solution, PNGaseF was added and incubated overnight at 37 ℃;
s5: freeze-drying the solution again and then carrying out nano-LC-MS/MS analysis;
in the above pretreatment process, the buffer solution is ACN-H2O-TFA, 92: 7.9: 0.1, v/v/v; the eluent is ACN-H2O,30:70,v/v。
The invention has the beneficial effects that:
the mHN/Au-GSH aggregates the one-dimensional structural characteristics of the nanofiber, the excellent hydrophilicity of glutathione and Fe3O4The strong magnetic response capability of the glycopeptide probe is integrated, and the glycopeptide probe has the excellent characteristics of high selectivity, high detection sensitivity, strong binding capability, good recovery efficiency and the like in the aspect of glycopeptide enrichment. Furthermore, the practical potential of mHN/Au-GSH nanofibers for glycoproteome analysis was demonstrated by enrichment of low abundance glycopeptides from human serum. The work provides a way for developing new hydrophilic nano-fibers and application thereof in the biomedical field;
the mHN/Au-GSH nanofiber has high glycopeptide detection sensitivity (2fmol), good recovery rate (89.65%), strong binding capacity (100mg/g) and high enrichment selectivity (1: 100).
Drawings
FIG. 1 is a synthesis process diagram of mHN/Au-GSH nano-fiber.
Fig. 2 is a TEM micrograph of HN (1).
Figure 3 is a TEM micrograph of HN (2).
Fig. 4 is a TEM micrograph (1) of mHN.
Fig. 5 is a TEM micrograph (2) of mHN.
FIG. 6 is a TEM micrograph of mHN/Au nanofibers (1).
FIG. 7 is a TEM micrograph of mHN/Au nanofibers (2).
FIG. 8 is an Energy Dispersive Spectroscopy (EDS) elemental distribution plot of the mHN/Au nanofibers prepared.
FIG. 9 is a graph of Fourier Transform Infrared (FTIR) spectral analysis results; wherein, (i) mHN/Au, (ii) mHN/Au-GSH, and (iii) GSH.
FIG. 10 is a diagram showing the result of XRD analysis; wherein, (i) HN, (ii) mHN, and (iii) mHN/Au.
FIG. 11 is a hysteresis loop curve of mHN and mHN/Au-GSH; wherein, (i) mHN, (ii) mHN/Au-GSH.
FIG. 12 is a MALDI-TOFMS spectrum of a direct analysis of a 0.4pmol human IgG digest.
FIG. 13 is a MALDI-TOFMS spectrum of mHN/Au-GSH enriched nanofibers.
FIG. 14 is a MALDI-TOFMS spectrum of mHN-GSH-enriched nanofibers.
FIG. 15 is a MALDI-TOFMS spectrum of HN/Au-GSH enriched nanofibers.
FIG. 16 is a MALDI-TOFMS spectrum enriched with commercial zwitterionic hydrophilic material.
FIG. 17 is a MALDI-TOFMS spectrum enriched by mHN/Au-GSH nanofibers and deglycosylated by PNGaseF.
FIG. 18 is a MALDI-TOF MS spectrum of a 0.25pmol chicken avidin digest direct analysis.
FIG. 19 is a MALDI-TOFMS spectrum enriched with mHN/Au-GSH nanofibers.
FIG. 20 is a MALDI-TOFMS spectrum of mHN/Au-GSH nanofiber enrichment after digestion of 20mmol human IgG.
FIG. 21 is a MALDI-TOFMS spectrum of mHN/Au-GSH nanofiber enrichment after 2mfmol human IgG digestion.
FIG. 22 is a MALDI-TOFMS spectrum of 20fmol human IgG after digestion and enrichment with commercial zwitterionic hydrophilic material.
FIG. 23 is a MALDI-TOFMS spectrum of 2fmol human IgG after digestion and enrichment with commercial zwitterionic hydrophilic material.
FIG. 24 is a MALDI-TOFMS spectrum of a peptide mixture containing a digest of human IgG and a digest of BSA analyzed directly.
FIG. 25 is a MALDI-TOFMS spectrum of a peptide mixture containing a digest of human IgG and a digest of BSA after enrichment with mHN/Au-GSH nanofibers.
Fig. 26 is a graph in which 1: MALDI-TOFMS spectrum of peptide mixture containing human IgG digest and BSA digest after enrichment of Au-GSH nanofibers at a mass ratio of mHN/100. In fig. 12-26, the glycopeptide peaks are labeled with the symbol "×".
Detailed Description
In order to make the technical solution of the present invention clearer and more clear, the present invention is further described below, and any solution obtained by substituting technical features of the technical solution of the present invention with equivalents and performing conventional reasoning falls within the scope of the present invention.
A magnetic nanofiber-based zwitterion hydrophilic material for selectively capturing and identifying glycopeptides utilizes hydroxyapatite nanofibers as a carrier to fix Fe3O4Nanoparticles and Au nanoparticles, via the thiol group of the zwitterionic tripeptide L-glutathione with Au and Fe3O4The surface modification is carried out through the affinity interaction between the two to form mHN/Au-GSH nano-fiber.
Further, the preparation method of the mHN/Au-GSH nano fiber comprises the following steps:
s1: dispersing 2.0g of hydroxyapatite nanofiber and 0.75g of ferric acetylacetonate in 400mL of triethylene glycol to obtain a mixture;
s2: the mixture was transferred to a 1L autoclave and reacted at 220 ℃ for 12 hours, washed with water and ethanol to give fixed Fe3O4A nanofiber product of nanoparticles mHN;
s3: 0.5g of prepared mHN and 25mL of tetrachloroauric acid trihydrate were added to 1L of deionized water to obtain a suspension;
s4: the suspension was stirred at 25 ℃ for 12 hours, 50mg of sodium borohydride was added and stirred for 30 minutes to obtain simultaneous fixed Fe3O4Nanofiber product mHN/Au of nanoparticles and Au nanoparticles;
s5: after washing with deionized water, 0.5g of the HN/Au product was dispersed in an aqueous solution containing 2g of glutathione; stirring at 50 deg.C for 10 hr to obtain mHN/Au-GSH nanofiber.
Further, the concentration of tetrachloroauric acid trihydrate in S3 was 2 mg/mL.
Further, mHN/Au-GSH nanofiber is used for enrichment and identification of glycopeptide.
Furthermore, the HN/Au-GSH nano-fiber can be used for pretreatment before ionization time-of-flight mass spectrometry analysis of human immunoglobulin, chicken avidin protein or bovine serum albumin; the method comprises the following specific steps:
s1: digesting human immunoglobulin, chicken avidin or bovine serum albumin with trypsin;
s2: 400 u g mHN/Au-GSH nanofibers and 2.5 u g human immunoglobulin digests, chicken avidin digests or bovine serum albumin digests into 400 u L buffer solution, at 25 degrees C temperature in 15 minutes;
s3: magnetically separating the material, washing with 2 × 400 μ L buffer solution, and adding 20 μ L eluent to elute and capture glycopeptide;
s4: depositing 1 μ L of the eluate and 1 μ L of DHB on a MALDI plate, and performing MALDI-TOFMS analysis;
in the above pretreatment process, the buffer solution is ACN-H2O-TFA, 92: 7.9: 0.1, v/v/v; eluentIs ACN-H2O, 30: 70, v/v; the concentration of DHB was 25 mg/mL.
Further, the mHN/Au-GSH nanofiber can be used for pretreatment before nano-LC-MS/MS analysis of human serum; the method comprises the following specific steps:
s1: trypsinizing human serum;
s2: 2mg of mHN/Au-GSH nanofibers were incubated with 5. mu.L of human serum digest in 1mL of buffer for 30 min;
s3: adding 2 × 100 μ L of the eluate, and lyophilizing the obtained eluate;
s4: the lyophilized sample was redissolved in 100. mu.L of 25 mmol. multidot.L-1To the sodium bicarbonate solution, PNGaseF was added and incubated overnight at 37 ℃;
s5: freeze-drying the solution again and then carrying out nano-LC-MS/MS analysis;
in the above pretreatment process, the buffer solution is ACN-H2O-TFA, 92: 7.9: 0.1, v/v/v; the eluent is ACN-H2O,30:70,v/v。
For further understanding of the present invention, the following embodiments are provided to illustrate the technical solutions of the present invention in detail, and the scope of the present invention is not limited by the following embodiments.
mHN/characterization of Au-GSH nanofibers
The synthesis of magnetic nanofiber-based zwitterionic hydrophilic materials (mHN/Au-GSH nanofibers) is given in FIG. 1. Briefly, one-dimensional Hydroxyapatite Nanofiber (HN) is synthesized by a solvothermal reaction method and used as modified Fe3O4Nanoparticles and Au nanoparticles. Subsequently, sulfhydryl groups in Glutathione (GSH) were reacted with Au and Fe3O4The nanoparticles react to allow glutathione to be immobilized on the magnetic nanofibers. The mHN/Au-GSH nanofiber has the characteristics of nanofiber, magnetic response capability and hydrophilic glutathione group, and can be used as an adsorbent to specifically capture glycopeptides in the sample preparation process of mass spectrometry glycopeptide omics research.
FIGS. 2, 3, 4, 5, 6 and 7 show the shapes of HN, mHN and mHN/Au nanofibers producedState. HN consists of hydroxyapatite nanowires with pronounced one-dimensional features, including nanometer-sized diameters of 10-20nm, high aspect ratio, and self-assembly into nanofibers (fig. 2, fig. 3). Compared to the smooth surface of HN, a large number of small nanoparticles with an average diameter of about 12nm were decorated at mHN (fig. 4, fig. 5). In addition, after the Au nanoparticles are fixed on mHN, more small nanoparticles appear on the MHN surface, and mHN/Au nanofibers are formed. The average particle size of the modified gold nanoparticles was calculated to be about 11.6nm using the Scherrer equation according to the X-ray diffraction (XRD) analysis results. In addition, the spatial element distribution of P, Ca, Fe and Au from mHN/Au nanofibers was studied using Energy Dispersive Spectroscopy (EDS) elemental mapping. As shown in fig. 8, the four element signals are uniformly localized, further confirming the signal peaks, revealing Fe3O4And successful immobilization of Au nanoparticles in mHN/Au nanofibers.
Modification of glutathione was confirmed by Fourier Transform Infrared (FTIR) spectroscopic analysis. In FIG. 9, a hydroxyl group (3573 cm)-1),PO4 3-Radicals (1093, 1031, 962, 605 and 565cm-1) Absorption peaks of (2), adsorbed water was observed in the infrared spectrum of mHN/Au (3436 and 1633 cm)-1)。565cm-1Absorption peak and Fe3O4(560cm-1) Overlap of characteristic absorption peaks of (a). In addition, fingerprint peaks belonging to glutathione were clearly found in fig. 9. These results demonstrate successful glutathione immobilization in Fe3O4And Au nanofibers.
In addition, the structure was also analyzed by XRD. In fig. 10, the characteristic peak of HN is consistent with the analysis result of hydroxyapatite. In contrast, the relative increase in intensity of the diffraction peak marked with the black symbol' at 35.5 ° is due to Fe in the mHNX ray diffraction pattern3O4Due to the magnetic component of (a). In addition, in the XRD pattern of mHN/Au nanofiber, a new peak with black symbol '#' at 38.3 ℃ belongs to Au.
As shown in FIG. 11, hysteresis loops of mHN and mHN/Au-GSH were determined, indicating that these two materials have a supermagnetic characteristic. The saturation magnetization values of mHN and mHN/Au-GSH were found to be 6, respectively.76 and 5.51emu g-1. Although the final nanofibers have a relatively low saturation magnetization value, it is sufficient to allow rapid magnetic separation of the nanofibers from aqueous solutions.
Glycopeptide enrichment performance of mHN/Au-GSH nanofiber measured by standard glycoprotein digestion method
Human immunoglobulin IgG trypsin digest was used as a model sample to study the glycopeptide enrichment performance of the prepared mHN/Au-GSH nanofibers. As shown in fig. 12, no glycopeptide peaks were observed in the non-enriched human IgG digest. However, after enrichment with mHN/Au-GSH nanofibers, the glycopeptide peak with strong signal intensity dominates the mass spectrum and there is hardly any interference from non-glycopeptide peaks (FIG. 13). We performed a total of 21 glycopeptides for detection and identification. In addition, mHN-GSH nanofibers, non-magnetic nanofibers (HN/Au-GSH), and commercial ZIC-HILIC materials were used as controls. In fig. 14, 15 and 16, only 17, 20 and 18 glycopeptide peaks were detected, respectively. After mHN/Au-GSH nanofiber enrichment, the identified glycopeptide peak has signal intensity and signal-to-noise ratio (S/N) which are obviously higher than those of a control material after treatment. For example, glycopeptide peaks enriched with mHN/Au-GSH, mHN-GSH, HN/Au-GSH, and commercial ZIC-HILIC materials have S/N ratios of 810.7, 464.7, 564.5, and 492.6 at a mass to charge ratio of 2764.1, respectively. The result shows that the enrichment performance of mHN/Au-GSH is superior to that of mHN-GSH, HN/Au-GSH and commercial ZIC-HILIC materials. In addition, the captured glycopeptide is deglycosylated by PNGaseF (glycoamidase). In FIG. 17, all the glycopeptide peaks detected disappeared, leaving only the two major deamidated peptides (EEQFN # STFR, EEQYN # STYR), indicating that all the peaks observed in FIG. 13 are related to N-bond glycopeptides. The unique one-dimensional structure, abundant zwitterion groups and strong magnetic responsiveness contribute to providing excellent enrichment performance. These results all confirm that the prepared mHN/Au-GSH nanofiber has high enrichment specificity and efficiency on glycopeptide.
In addition, a trypsin digest of chicken avidin was also used. Mass spectra of chicken avidin digests As shown in FIG. 18, 8 glycopeptide peaks with low signal intensity and S/N ratio were observed due to the simultaneous presence of a large number of non-glycopeptides. Importantly, after the selective enrichment process using mHN/Au-GSH nanofibers, the 14 glycopeptide peaks in the mass spectrum (FIG. 19) were affected with improved signal intensity and S/N ratio. These analysis results demonstrate that the prepared mHN/Au-GSH nanofibers have high selectivity and efficiency for general glycopeptide enrichment.
The detection sensitivity of the prepared mHN/Au-GSH nanofiber to glycopeptide is determined. As shown in fig. 20, 12 glycopeptide peaks were clearly observed in a 20fmol human immunoglobulin IgG digest after the enrichment process. When the amount of human IgG digestion was as low as 2fmol (FIG. 21), four glycopeptide peaks were still observed, with a maximum S/N ratio of 22.8. The detection sensitivity of mHN/Au-GSH nanofiber for glycopeptide was considered to be 2 fmol. For comparison, the detection sensitivity of commercial hydrophilic materials was also tested. When the amount of human IgG digestion was 20fmol and enriched with commercial hydrophilic material, only 8 glycopeptide peaks could be detected (fig. 22). On the other hand, when the amount of human IgG digested was only 2fmol (FIG. 23), no glycopeptide peak was observed. The mHN/Au-GSH nanofiber studied at this time has higher detection sensitivity on abundant low-abundance glycopeptides, and the performance of the nanofiber is superior to that of CS @ PGMA @ IDA-Ti4+(45fmol)、GO-Fe3O4/SiO2AuNWs/L-cysteine (10fmol), MoS2Au-NP-L-cysteine (10fmol) and Fe3O4@ TpPa are several hydrophilic materials.
According to the previous literature, the recovery of enrichment of 6 targeted glycopeptides released from human IgG was evaluated by isotopic dimethyl labelling. The average enrichment recovery achieved was 89.65%. Compared with Resin @ Polysaccharide (73%), GO/Fe which are reported in the past3O4/Au/PEG(59.2%)、Fe3O4@MPS@PMAC(82%)、MIL-101(NH2) Compared with several hydrophilic materials of @ Au-Cysteine (80%) and Resin/Au-Cysteine (79%), the mHN/Au-GSH nanofiber prepared by the method has better capture capability.
At the same time, the binding capacity of the confirmed mHN/Au-GSH nanofiber is measured. A fixed mass of human IgG digest (3. mu.g) was incubated with a mass of mHN/Au-GSH. After a period of time, the detection is carried out when mHN/Au-GSH is usedAt 30. mu.g, the signal intensities of the six selected glycopeptides reached a maximum. mHN/Au-GSH nano-fiber with glycopeptide binding capacity of 100mg g-1. This is probably due to the strong multivalent hydrophilic interaction between the glycopeptide and the MHN/Au-GSH nanofibers due to the abundance of zwitterionic hydrophilic groups. The experiment result shows that the combination capability of the MHN/Au-GSH nano-fiber is stronger than that of Fe3O4@CSMCNCs(17.5mg/g)、Fe3O4-DA-Maltose (43mg/g) and Fe3O4@PGMA@Au-L-cysteine(75mg/g)。
The enrichment selectivity of mHN/Au-GSH nanofibers was further investigated. As shown in fig. 24, by directly analyzing the polypeptide mixture containing the human IgG digest and the BSA digest, we found that the non-glycopeptide peak was dominant in the mass spectrum and that the glycopeptide peak was not clearly identified. However, after enrichment with mHN/Au-GSH nanofibers, the non-glycopeptides disappeared significantly, and the signal intensities of 19 and 17 glycopeptides detected were significantly improved (FIGS. 25 and 26), which provides more evidence for enrichment of glycopeptides with mHN/Au-GSH nanofibers.
Selective enrichment and identification of glycopeptides in human serum
Human serum has attracted considerable attention as a typical clinical specimen, a potential biomarker for diagnosing diseases. The advantages of mHN/Au-GSH nanofiber in glycopeptide enrichment prove that human serum glycoprotein is analyzed according to the scheme of proteolysis, mHN/Au-GSH nanofiber glycopeptide enrichment, PNGase F deglycosylation and mass spectrum identification. As a result, a total of 246 glycopeptides of 104 glycoproteins were identified by only three independent analyses of 1. mu.L human serum. In contrast, commercial zwitterionic hydrophilic materials identified only 162 glycopeptides from 69 glycoproteins. The structural differences of these affinity materials contribute to their diverse abilities in glycopeptide enrichment. These results indicate that the prepared mHN/Au-GSH nanofiber has high specificity and high efficiency in capturing low-abundance glycopeptides, and has great potential in researching the glycoproteome of complex biological samples.
The experimental procedures in this example are conventional, unless otherwise specified. The experimental materials used in the present examples were all purchased from the market unless otherwise specified.
Transmission Electron Microscope (TEM) images and Energy Dispersive Spectroscopy (EDS) elemental mapping were obtained with a transmission electron microscope (feitecnag 2F20, USA). The infrared spectra were obtained using a Thermo Nicolet380 Fourier transform infrared spectrometer (Nicolet, Wisconsin, USA). X-ray diffractometry (RigakuD/max2550V, CuK alpha radiation,
Figure BDA0002040444220000141
) An X-ray powder diffraction (XRD) pattern was recorded. The saturation magnetization curve was tested on a physical property measurement system (PPMS, USA) at room temperature. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) experiments were performed in linear positive mode on an AB Sciex5800 mass spectrometer (ABSciex, CA) using a Nd/YAG laser at 355 nm.

Claims (2)

1. The magnetic nanofiber-based zwitterion hydrophilic material for selectively capturing and identifying glycopeptides is characterized in that the magnetic nanofiber-based zwitterion hydrophilic material is prepared by fixing Fe by taking hydroxyapatite nanofiber as a carrier3O4Nanoparticles and Au nanoparticles, via the thiol group of the zwitterionic tripeptide L-glutathione with Au and Fe3O4The surface modification is carried out by the affinity interaction, and the specific preparation method comprises the following steps:
s1: dispersing 2.0g of hydroxyapatite nanofiber and 0.75g of ferric acetylacetonate in 400mL of triethylene glycol to obtain a mixture;
s2: the mixture was transferred to a 1L autoclave and reacted at 220 ℃ for 12 hours, washed with water and ethanol to give fixed Fe3O4A nanofiber product of nanoparticles mHN;
s3: 0.5g of prepared mHN and 25mL of tetrachloroauric acid trihydrate were added to 1L of deionized water to obtain a suspension;
s4: the suspension was stirred at 25 ℃ for 12 hours, 50mg of sodium borohydride was added and stirred for 30 minutes to obtain simultaneous fixed Fe3O4Nanofiber product mH of nanoparticles and Au nanoparticlesN/Au;
S5: after washing with deionized water, 0.5g of the mHN/Au product was dispersed in an aqueous solution containing 2g of the zwitterionic tripeptide L-glutathione; stirring for 10 hours at 50 ℃ to obtain the magnetic nanofiber-based zwitterionic hydrophilic material.
2. The magnetic nanofiber-based zwitterionic hydrophilic material for selectively capturing and recognizing a glycopeptide according to claim 1, wherein the concentration of tetrachloroaurate trihydrate in S3 is 2 mg/mL.
CN201910340139.3A 2019-04-25 2019-04-25 Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides Expired - Fee Related CN110130099B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910340139.3A CN110130099B (en) 2019-04-25 2019-04-25 Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910340139.3A CN110130099B (en) 2019-04-25 2019-04-25 Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides

Publications (2)

Publication Number Publication Date
CN110130099A CN110130099A (en) 2019-08-16
CN110130099B true CN110130099B (en) 2021-06-08

Family

ID=67571212

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910340139.3A Expired - Fee Related CN110130099B (en) 2019-04-25 2019-04-25 Magnetic nanofiber-based zwitterionic hydrophilic materials for selective capture and recognition of glycopeptides

Country Status (1)

Country Link
CN (1) CN110130099B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111841511A (en) * 2020-07-13 2020-10-30 浙江农林大学 Magnetic nanoparticle-graphene oxide nanocomposite and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723311A (en) * 2009-11-06 2010-06-09 武汉理工大学 Magnetic flourescent nano material for magnetic-photo sensor and preparation method thereof
CN102431986A (en) * 2011-10-08 2012-05-02 山东大学 Method for preparing hydroxyapatite nano fiber
CN105823847A (en) * 2016-03-16 2016-08-03 复旦大学 Glycopeptide enriching and detecting method of amphoteric hydrophilic composite nano material
CN105862391A (en) * 2016-03-29 2016-08-17 苏州大学 Preparation method of BC@metal oxide composite nanofiber
CN107083241A (en) * 2017-06-19 2017-08-22 中南大学 Water soluble hydroxy apatite fluorescent nano-particle and its preparation and activity and the method for inhibition for testing and analyzing PKA
CN107486177A (en) * 2017-09-15 2017-12-19 四川大学 Magnetic metal organic framework nanosphere with how affine site and preparation method and application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723311A (en) * 2009-11-06 2010-06-09 武汉理工大学 Magnetic flourescent nano material for magnetic-photo sensor and preparation method thereof
CN102431986A (en) * 2011-10-08 2012-05-02 山东大学 Method for preparing hydroxyapatite nano fiber
CN105823847A (en) * 2016-03-16 2016-08-03 复旦大学 Glycopeptide enriching and detecting method of amphoteric hydrophilic composite nano material
CN105862391A (en) * 2016-03-29 2016-08-17 苏州大学 Preparation method of BC@metal oxide composite nanofiber
CN107083241A (en) * 2017-06-19 2017-08-22 中南大学 Water soluble hydroxy apatite fluorescent nano-particle and its preparation and activity and the method for inhibition for testing and analyzing PKA
CN107486177A (en) * 2017-09-15 2017-12-19 四川大学 Magnetic metal organic framework nanosphere with how affine site and preparation method and application

Also Published As

Publication number Publication date
CN110130099A (en) 2019-08-16

Similar Documents

Publication Publication Date Title
Chen et al. Facile synthesis of zwitterionic polymer-coated core–shell magnetic nanoparticles for highly specific capture of N-linked glycopeptides
Wang et al. Facile synthesis of magnetic covalent organic frameworks for the hydrophilic enrichment of N-glycopeptides
Yao et al. One-step functionalization of magnetic nanoparticles with 4-mercaptophenylboronic acid for a highly efficient analysis of N-glycopeptides
Huan et al. A magnetic nanofiber-based zwitterionic hydrophilic material for the selective capture and identification of glycopeptides
Jiao et al. Ultrathin Au nanowires assisted magnetic graphene-silica ZIC-HILIC composites for highly specific enrichment of N-linked glycopeptides
Kailasa et al. Nanomaterial-based miniaturized extraction and preconcentration techniques coupled to matrix-assisted laser desorption/ionization mass spectrometry for assaying biomolecules
Pan et al. Dual-functionalized magnetic bimetallic metal-organic framework composite for highly specific enrichments of phosphopeptides and glycopeptides
Wu et al. Thiol-ene click synthesis of L-cysteine-bonded zwitterionic hydrophilic magnetic nanoparticles for selective and efficient enrichment of glycopeptides
Xu et al. Boronic acid-functionalized detonation nanodiamond for specific enrichment of glycopeptides in glycoproteome analysis
Zhao et al. Synthesis of magnetic zwitterionic–hydrophilic material for the selective enrichment of N-linked glycopeptides
Zheng et al. Click synthesis of glucose-functionalized hydrophilic magnetic mesoporous nanoparticles for highly selective enrichment of glycopeptides and glycans
Zhao et al. Recent advances in the application of core–shell structured magnetic materials for the separation and enrichment of proteins and peptides
Feng et al. Facile and easily popularized synthesis of L-cysteine-functionalized magnetic nanoparticles based on one-step functionalization for highly efficient enrichment of glycopeptides
Zhang et al. Phenylboronic acid functionalized C3N4 facultative hydrophilic materials for enhanced enrichment of glycopeptides
Ma et al. Ligand-free strategy for ultrafast and highly selective enrichment of glycopeptides using Ag-coated magnetic nanoarchitectures
CN107727480B (en) Ultrathin lamellar functionalized molybdenum disulfide nano composite material and application thereof in glycopeptide enrichment
Long et al. Low-cost iron oxide magnetic nanoclusters affinity probe for the enrichment of endogenous phosphopeptides in human saliva
Chu et al. One-pot preparation of hydrophilic citric acid-magnetic nanoparticles for identification of glycopeptides in human saliva
CN106732474B (en) Magnetic nano material, preparation method thereof and application of magnetic nano material in enrichment analysis of glycosylated peptide segments
Li et al. Preparation of titanium-grafted magnetic mesoporous silica for the enrichment of endogenous serum phosphopeptides
CN110779789A (en) Preparation of hydrophilic group modified two-dimensional magnetic nano material and application of hydrophilic group modified two-dimensional magnetic nano material in large-scale enrichment of glycopeptide
Chen et al. Preparation of C60‐functionalized magnetic silica microspheres for the enrichment of low‐concentration peptides and proteins for MALDI‐TOF MS analysis
Pu et al. Elution-free ultra-sensitive enrichment for glycopeptides analyses: Using a degradable, post-modified Ce-metal–organic framework
Zhang et al. L-cysteine functionalized straticulate C3N4 for the selective enrichment of glycopeptides
CN108906007A (en) A kind of preparation method and applications of the hydrophilic magnetic composite microballoon of glycosyl

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210608

CF01 Termination of patent right due to non-payment of annual fee